Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexvix vs Standard Cystoscopy in Non-invasive Bladder Cancer
NCT00412971Phase 3Completed
- Sponsor
- Photocure
- Start
- Apr 2005
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hexaminolevulinate in bladder cancer (2 arms), sponsored by Photocure. Primary endpoint: Proportion of Patients With Histologically Confirmed Recurrence Within One 1 Year. Started Apr 2005; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00412971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412971.